MX382815B - Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas. - Google Patents
Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas.Info
- Publication number
- MX382815B MX382815B MX2018004175A MX2018004175A MX382815B MX 382815 B MX382815 B MX 382815B MX 2018004175 A MX2018004175 A MX 2018004175A MX 2018004175 A MX2018004175 A MX 2018004175A MX 382815 B MX382815 B MX 382815B
- Authority
- MX
- Mexico
- Prior art keywords
- applications
- preparation
- derivative
- medicines
- oxa
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 3
- 208000002193 Pain Diseases 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 230000036407 pain Effects 0.000 abstract 2
- 125000003003 spiro group Chemical group 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se relaciona con un derivado oxa espiro, un método de preparación del mismo, y aplicaciones del mismo en medicinas. Particularmente, la presente invención se relaciona con un derivado oxa espiro representado por la fórmula (I), un método de preparación del mismo, y una composición farmacéutica que comprende el derivado, las aplicaciones del mismo como un agonista del receptor MOR, y aplicaciones en la preparación de fármacos para tratar y/o evitar los dolores y los dolores relacionados con las enfermedades. Los grupos de sustitución en la fórmula (I) son los mismos que las definiciones en la especificación.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510665328 | 2015-10-15 | ||
| CN201511032876 | 2015-12-31 | ||
| PCT/CN2016/101064 WO2017063509A1 (zh) | 2015-10-15 | 2016-09-30 | 氧杂螺环类衍生物、其制备方法及其在医药上的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018004175A MX2018004175A (es) | 2018-06-06 |
| MX382815B true MX382815B (es) | 2025-03-12 |
Family
ID=58517778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018004175A MX382815B (es) | 2015-10-15 | 2016-09-30 | Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10442793B2 (es) |
| EP (1) | EP3354649B1 (es) |
| JP (1) | JP6824502B2 (es) |
| KR (1) | KR102703513B1 (es) |
| CN (1) | CN107001347B (es) |
| AU (1) | AU2016339404B2 (es) |
| CA (1) | CA3000761C (es) |
| DK (1) | DK3354649T3 (es) |
| ES (1) | ES2772689T3 (es) |
| HU (1) | HUE048032T2 (es) |
| MX (1) | MX382815B (es) |
| PL (1) | PL3354649T3 (es) |
| PT (1) | PT3354649T (es) |
| RU (1) | RU2733373C2 (es) |
| TW (1) | TWI727981B (es) |
| WO (1) | WO2017063509A1 (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3610875T (lt) * | 2017-04-14 | 2020-11-25 | Jiangsu Hengrui Medicine Co., Ltd. | Opioido (mor) agonisto druska, jo fumarato druskos i kristalinė forma ir jos gavimo būdas |
| CN108727347B (zh) * | 2017-04-14 | 2020-06-16 | 江苏恒瑞医药股份有限公司 | 一种阿片样物质受体(mor)激动剂的晶型及其制备方法 |
| TW201836606A (zh) * | 2017-04-14 | 2018-10-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 一種mor激動劑與kor激動劑聯合在製備緩解和/或治療疼痛的藥物中的用途 |
| CN115124520A (zh) * | 2017-07-04 | 2022-09-30 | 四川海思科制药有限公司 | 阿片受体激动剂及其应用 |
| CN109516982B (zh) | 2017-09-18 | 2022-08-23 | 上海华汇拓医药科技有限公司 | μ-阿片受体激动剂及其制备方法和在医药领域的应用 |
| CA3076395A1 (en) * | 2017-09-28 | 2019-04-04 | Jiangsu Hengrui Medicine Co., Ltd. | Method for preparing oxaspirocycle derivative, and intermediate thereof |
| CN111148515B (zh) * | 2017-10-13 | 2022-07-19 | 山东绿叶制药有限公司 | 2,6-二氧杂螺[4,5]癸烷类衍生物、其制备方法及其在医药上的应用 |
| MX2020005660A (es) * | 2017-12-06 | 2020-08-20 | Jiangsu Hengrui Medicine Ltd | Uso de un agonista de kor en combinacion con un agonista de mor para preparar medicamentos para tratar el dolor. |
| WO2019205983A1 (zh) * | 2018-04-28 | 2019-10-31 | 四川科伦博泰生物医药股份有限公司 | 氧杂螺环类化合物及其制备方法和用途 |
| CN108424372B (zh) * | 2018-05-11 | 2021-08-10 | 浙江华贝药业有限责任公司 | 2,2,2-三氟-n-[(s)-4-羰基四氢萘-1-基]-乙酰胺的纯化工艺 |
| TW202015678A (zh) * | 2018-05-14 | 2020-05-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 一種mor受體激動劑醫藥組成物 |
| CN108707086B (zh) * | 2018-05-15 | 2021-08-10 | 浙江华贝药业有限责任公司 | 一种(1s,4s)-n-(4-羟基四氢萘-1-基)叔丁氧基碳酰胺的纯化工艺 |
| WO2020073985A1 (zh) * | 2018-10-12 | 2020-04-16 | 江苏恒瑞医药股份有限公司 | 一种阿片样物质受体(mor)激动剂的结晶形式及制备方法 |
| WO2020073984A1 (zh) * | 2018-10-12 | 2020-04-16 | 江苏恒瑞医药股份有限公司 | 一种阿片样物质受体(mor)激动剂的结晶形式及制备方法 |
| CN112334465B (zh) * | 2019-01-17 | 2024-06-11 | 上海海雁医药科技有限公司 | 三环取代的氧杂螺环衍生物、其制法与医药上的用途 |
| CN111662284B (zh) * | 2019-03-06 | 2021-08-10 | 上海海雁医药科技有限公司 | 双杂环取代的氧杂螺环衍生物、其制法与医药上的用途 |
| WO2021027304A1 (zh) * | 2019-08-14 | 2021-02-18 | 上海海雁医药科技有限公司 | 镇痛化合物、其制法与医药上的用途 |
| EP4092031A4 (en) | 2020-01-17 | 2024-02-21 | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | AZABICYCLIC SUBSTITUTED OXASPIRO DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND ITS MEDICAL USE |
| CN114269751B (zh) * | 2020-01-17 | 2024-04-16 | 上海海雁医药科技有限公司 | 光学纯的氧杂螺环取代的吡咯并吡唑衍生物、其制法与医药上的用途 |
| CN113214264B (zh) * | 2020-01-21 | 2022-08-09 | 上海海雁医药科技有限公司 | 二氢吡咯并五元杂芳基取代的氧杂螺环衍生物、其制法与医药上的用途 |
| US20230101735A1 (en) | 2020-01-22 | 2023-03-30 | Jiangsu Hengrui Medicine Co., Ltd. | Anti-trop-2 antidody-exatecan analog conjugate and medical use thereof |
| CN114075141B (zh) * | 2020-08-20 | 2025-02-25 | 上海致根医药科技有限公司 | 阿片受体“偏向性”配体、其制备方法及其在医药上的应用 |
| CN114539257B (zh) * | 2020-11-24 | 2023-08-11 | 江苏恒瑞医药股份有限公司 | 嘧啶二酮类螺环衍生物、其制备方法及其在医药上的应用 |
| EP4265604B1 (en) | 2020-12-29 | 2026-04-01 | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Oxaspiro substituted pyrrolopyrazole derivative, intermediate thereof, and preparation method therefor |
| EP4361154A4 (en) * | 2021-07-13 | 2025-06-18 | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Pharmaceutically acceptable salt of a Mor receptor agonist, polymorph thereof, and use thereof |
| AU2022322838B2 (en) * | 2021-08-02 | 2024-12-12 | Jiangsu Nhwa Pharmaceutical Co., Ltd | Oxaspiro derivative, and preparation method therefor and use thereof |
| CN117263956A (zh) * | 2022-01-19 | 2023-12-22 | 天地恒一制药股份有限公司 | 阿片受体激动剂及其制备方法和用途 |
| CN116589451B (zh) * | 2022-02-11 | 2024-07-09 | 成都硕德药业有限公司 | 一种6-氧杂螺[4,5]癸烷类化合物的新晶型、用途及其制备方法 |
| CN117624138A (zh) * | 2022-08-29 | 2024-03-01 | 江苏恒瑞医药股份有限公司 | 一种氧杂螺环类衍生物的可药用盐、晶型及制备方法 |
| CN119894904B (zh) * | 2022-09-27 | 2025-12-30 | 上海枢境生物科技有限公司 | 一种含螺环类衍生物的盐、晶型及其制备方法和应用 |
| KR20250137614A (ko) | 2023-01-18 | 2025-09-18 | 상하이 센후이 메디슨 컴퍼니 리미티드 | 테트라히드로-1-나프틸아민 및 이의 유도체의 제조 방법 |
| WO2026026772A1 (zh) * | 2024-07-30 | 2026-02-05 | 上海枢境生物科技有限公司 | 氧杂螺环类衍生物的富马酸盐晶型及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2160534B1 (es) | 1999-12-30 | 2002-04-16 | Vita Invest Sa | Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo. |
| DE10044649A1 (de) | 2000-09-08 | 2002-07-04 | Gruenenthal Gmbh | Substituierte 4-Phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine |
| DE102006033109A1 (de) | 2006-07-18 | 2008-01-31 | Grünenthal GmbH | Substituierte Heteroaryl-Derivate |
| US7999107B2 (en) * | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
| WO2009018169A1 (en) | 2007-07-27 | 2009-02-05 | Auspex Pharmaceuticals, Inc. | Substituted cyclohexanols |
| CA2779252C (en) * | 2008-10-31 | 2015-05-05 | Pain Therapeutics, Inc. | Filamin a-binding anti-inflammatory analgesic |
| WO2010148191A2 (en) | 2009-06-17 | 2010-12-23 | Board Of Regents, The University Of Texas System | Compositions and methods for cyclofructans as separation agents |
| ME02754B (me) * | 2011-03-23 | 2018-01-20 | Trevena Inc | Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme |
| HUE029070T2 (en) | 2011-12-12 | 2017-02-28 | Gruenenthal Gmbh | (1R, 4R) -6'-Fluoro (N, N-Dimethyl- and N-methyl) -4-phenyl-4 ', 9'-dihydro-3'H-spiro [cyclohexane-1,1'- pyrano- [3,4, B] indole] -4-amine |
| SI2880037T1 (sl) | 2012-08-03 | 2019-04-30 | Johnson Matthey Public Limited Company | Postopek za pripravo oksikodona |
| CA2891334C (en) | 2012-11-13 | 2021-10-19 | Array Biopharma Inc. | Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain |
-
2016
- 2016-09-30 EP EP16854888.1A patent/EP3354649B1/en active Active
- 2016-09-30 CA CA3000761A patent/CA3000761C/en active Active
- 2016-09-30 CN CN201680003945.6A patent/CN107001347B/zh active Active
- 2016-09-30 PL PL16854888T patent/PL3354649T3/pl unknown
- 2016-09-30 ES ES16854888T patent/ES2772689T3/es active Active
- 2016-09-30 WO PCT/CN2016/101064 patent/WO2017063509A1/zh not_active Ceased
- 2016-09-30 AU AU2016339404A patent/AU2016339404B2/en active Active
- 2016-09-30 DK DK16854888.1T patent/DK3354649T3/da active
- 2016-09-30 US US15/766,985 patent/US10442793B2/en active Active
- 2016-09-30 RU RU2018115569A patent/RU2733373C2/ru active
- 2016-09-30 PT PT168548881T patent/PT3354649T/pt unknown
- 2016-09-30 JP JP2018515975A patent/JP6824502B2/ja active Active
- 2016-09-30 HU HUE16854888A patent/HUE048032T2/hu unknown
- 2016-09-30 KR KR1020187012600A patent/KR102703513B1/ko active Active
- 2016-09-30 MX MX2018004175A patent/MX382815B/es unknown
- 2016-10-14 TW TW105133229A patent/TWI727981B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018115569A (ru) | 2019-11-18 |
| PT3354649T (pt) | 2020-02-03 |
| CA3000761C (en) | 2024-02-13 |
| KR20180063251A (ko) | 2018-06-11 |
| EP3354649A4 (en) | 2018-08-08 |
| KR102703513B1 (ko) | 2024-09-06 |
| CN107001347A (zh) | 2017-08-01 |
| TWI727981B (zh) | 2021-05-21 |
| AU2016339404A1 (en) | 2018-05-24 |
| CA3000761A1 (en) | 2017-04-20 |
| RU2733373C2 (ru) | 2020-10-01 |
| RU2018115569A3 (es) | 2020-01-20 |
| DK3354649T3 (da) | 2020-02-24 |
| JP2018534257A (ja) | 2018-11-22 |
| ES2772689T3 (es) | 2020-07-08 |
| PL3354649T3 (pl) | 2020-07-27 |
| MX2018004175A (es) | 2018-06-06 |
| EP3354649A1 (en) | 2018-08-01 |
| CN107001347B (zh) | 2019-09-24 |
| HUE048032T2 (hu) | 2020-05-28 |
| BR112018006448A2 (pt) | 2018-10-16 |
| US10442793B2 (en) | 2019-10-15 |
| TW201718558A (zh) | 2017-06-01 |
| WO2017063509A1 (zh) | 2017-04-20 |
| US20180297988A1 (en) | 2018-10-18 |
| AU2016339404B2 (en) | 2020-08-27 |
| EP3354649B1 (en) | 2019-12-04 |
| JP6824502B2 (ja) | 2021-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018004175A (es) | Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas. | |
| CL2019001744A1 (es) | Derivados de benzoxazol como inmunomoduladores. | |
| CO2018004124A2 (es) | Compuestos heterocíclicos | |
| NI201700096A (es) | Derivados de 4h-pirrol[3, 2-c]piridin-4-ona | |
| CL2018003323A1 (es) | Piridinas sustituidas con heteroarilo y métodos de uso. | |
| MX372914B (es) | Derivado de piperidina y metodo de preparacion y uso farmaceutico del mismo. | |
| CO2017011851A2 (es) | Compuestos novedosos | |
| CL2018001685A1 (es) | Compuestos heterociclicos como inmuno moduladores. | |
| CL2018000542A1 (es) | Nuevos derivados de fenoximetilo. | |
| EA201890126A1 (ru) | Новые бициклические производные, способ их получения и фармацевтические композиции, содержащие их | |
| ECSP17081744A (es) | Nuevos derivados hidroxiéster,un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| MX378194B (es) | Compuestos organicos. | |
| NI201600144A (es) | Derivados de quinoxalina utiles como moduladores del fgfr cinasa | |
| BR112016012146A2 (pt) | Compostos derivados de aminopiridina como inibidores quinase da família tam, composição farmacêutica compreendendo ditos compostos e uso terapêutico dos mesmos | |
| EA201892838A1 (ru) | Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их | |
| SV2018005760A (es) | Derivados de aminotiazol utiles como agentes antiviricos | |
| MX2015012456A (es) | Compuestos heterociclicos y usos de los mismos. | |
| MX374452B (es) | Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades. | |
| BR112016022069A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| MX2016015565A (es) | Ciertos inhibidores de la proteina quinasa. | |
| UY36175A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| MX387235B (es) | Derivados de pirazolopiridina y su uso en terapia | |
| UY35906A (es) | Novedosos derivados de bencimidazol como ligandos de ep4 | |
| EA201600124A1 (ru) | Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| CR20160460A (es) | Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados |